30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Ortho RTi Confirms Timeline to Initiate Human Clinical Program in Rotator Cuff Repair -

Ortho Regenerative Technologies (Ortho RTi) announced that following a formal meeting with FDA, the company can submit its Investigational New Drug (IND) for Ortho-R biopolymer for rotator cuff repair while completing its pivotal study, and will initiate a human clinical program by year-end. The proprietary biopolymer has been designed to increase the healing rates of sports related injuries to tendons, meniscus, ligaments and cartilage. It can be placed directly into the injury site during a routine surgical procedure without significantly extending the length of the surgery and without further intervention. (Ortho Regenerative Technologies, 2/27/19)